Status:

TERMINATED

Evaluating the Impact of Cerebral Ischemic And Degenerative Changes On Cognition

Lead Sponsor:

Lahey Clinic

Conditions:

Cognitive Decline

Eligibility:

All Genders

50+ years

Brief Summary

The purpose of this study is to evaluate whether or not cerebral atrophy scores obtained from a brain MRI can correlate with Cognitive Test results. These results hope to demonstrate a link between ce...

Detailed Description

Preliminary evidence indicates that intracranial atherosclerosis may predict incident cerebrovascular events and central atrophy. Age induced changes on cerebral tissue in adulthood is witnessed as at...

Eligibility Criteria

Inclusion

  • Subjects older than 50 years of age
  • Subjects who have undergone Cognitive Testing
  • Subjects who can cooperate and give informed consent

Exclusion

  • Subjects with known medical conditions predisposing them for atrophy such as: Chronic renal failure, HIV, head/neck tumors, prior radiation, post- traumatic brain disorder, metabolic disorders of brain, polysubstance abuse, and steroid use

Key Trial Info

Start Date :

February 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 1 2017

Estimated Enrollment :

170 Patients enrolled

Trial Details

Trial ID

NCT00704327

Start Date

February 1 2008

End Date

March 1 2017

Last Update

December 21 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Lahey Clinic, Inc.

Burlington, Massachusetts, United States, 01805